Editorial
Copyright ©2010 Baishideng Publishing Group Co.
World J Radiol. Nov 28, 2010; 2(11): 417-424
Published online Nov 28, 2010. doi: 10.4329/wjr.v2.i11.417
Figure 1
Figure 1 A 61-year-old man with 1. 5-cm recurrent hepatocellular carcinoma after ablation therapy in segment 5 of the liver. A: Early-phase dynamic computed tomography (CT) scan shows recurrent tumor (circle). Non-enhanced area (arrowheads) was previously treated by radiofrequency ablation (RFA); B: Contrast harmonic ultrasound (US) using Levovist shows enhancement of viable focus of a hepatocellular carcinoma (HCC) nodule (circle); C: Portal-phase dynamic CT scan, which was obtained 3 d after RFA shows that the tumor was not enhanced, indicating complete necrosis of the lesion (arrow); D: Contrast harmonic US, which was obtained 3 d after ablation shows non-enhanced area (circle).